NCI: Breast Cancer Cases Could Rise by 50 Percent

A National Cancer Institute model forecasts a marked increase in estrogen receptor-positive tumors among older women by 2030.

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

WIKIMEDIA, NCIAs the population of the U.S. grows and the average citizen lives longer, the total number of breast cancer cases among American women could be as much as 50 percent greater in 2030 than it was in 2011, according to a new forecast by the National Cancer Institute (NCI). NCI biostatistician Philip Rosenberg presented the findings yesterday (April 20) at the annual meeting of the American Association for Cancer Research (AACR) being held in Philadelphia.

Rosenberg explained that he NCI model predicts that the proportion of estrogen receptor (ER)-positive, in-situ breast cancer may rise from 19 percent to 29 percent, while rates of ER-negative breast cancer diagnoses will plateau or decrease. “Our estimate is that the total number of diagnoses of breast cancer in the U.S. will increase by about 50 percent by 2030,” he said during a press conference announcing the results. “The one silver lining is that we expect fewer ER-negative tumors, which include the most difficult-to-treat HER2-positive and triple-negative subtypes,” Rosenberg added in a statement.

The total number of new breast cancer cases in the U.S. will likely increase from 283,000 in 2011 to 441,000 in 2030, according to the NCI model, which incorporated data from the ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • Bob Grant

    From 2017 to 2022, Bob Grant was Editor in Chief of The Scientist, where he started in 2007 as a Staff Writer.
Share
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo
New Frontiers in Vaccine Development

New Frontiers in Vaccine Development

Sino

Products

Tecan Logo

Tecan introduces Veya: bringing digital, scalable automation to labs worldwide

Explore a Concise Guide to Optimizing Viral Transduction

A Visual Guide to Lentiviral Gene Delivery

Takara Bio
Inventia Life Science

Inventia Life Science Launches RASTRUM™ Allegro to Revolutionize High-Throughput 3D Cell Culture for Drug Discovery and Disease Research

An illustration of differently shaped viruses.

Detecting Novel Viruses Using a Comprehensive Enrichment Panel

Twist Bio